Hizentra 20% subcutaneous injection 2g/10mL (YJ code: 6343439A2020, 2g 10mL 1 bottle), manufactured by CSL Behring, contains pH4 treated acidic human immunoglobulin (subcutaneous injection). It is used for primary immunodeficiency (PI) and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
Hizentra 20% subcutaneous injection 2g/10mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →